These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 38404083

  • 1. Bony lesion analysis in carcinoma prostate: methylene diphosphonate bone scan vs. Gallium-68 psma-11 pet/ct.
    Ali H, Rashid Ul Amin S, Hai A, Nizar N.
    J Ayub Med Coll Abbottabad; 2023; 35(3):415-418. PubMed ID: 38404083
    [Abstract] [Full Text] [Related]

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 3. Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT.
    Caglar M, Tuncel M, Yildiz E, Karabulut E.
    Ann Nucl Med; 2020 Dec; 34(12):932-941. PubMed ID: 32975741
    [Abstract] [Full Text] [Related]

  • 4. Phase 2 trial of PSMA PET CT versus planar bone scan and CT in prostate cancer patients progressing while on androgen deprivation therapy.
    Nikitas J, Gafita A, Benz MR, Djaïleb L, Farolfi A, Hotta M, Sonni I, Alano R, Rettig M, Shen J, Armstrong W, Grogan T, Liu S, Czernin J, Calais J.
    Sci Rep; 2024 Oct 18; 14(1):24411. PubMed ID: 39420060
    [Abstract] [Full Text] [Related]

  • 5. Head-To-Head Comparison of 68Ga-PSMA-11 PET/CT and 99mTc-MDP Bone Scintigraphy for the Detection of Bone Metastases in Patients With Prostate Cancer: A Meta-Analysis.
    Zhao G, Ji B.
    AJR Am J Roentgenol; 2022 Sep 18; 219(3):386-395. PubMed ID: 35441529
    [Abstract] [Full Text] [Related]

  • 6. 68Ga-PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli?
    Lengana T, Lawal IO, Boshomane TG, Popoola GO, Mokoala KMG, Moshokoa E, Maes A, Mokgoro NP, Van de Wiele C, Vorster M, Sathekge MM.
    Clin Genitourin Cancer; 2018 Oct 18; 16(5):392-401. PubMed ID: 30120038
    [Abstract] [Full Text] [Related]

  • 7. The diagnostic accuracy of 68Ga-PSMA PET/CT versus 99mTc-MDP bone scintigraphy for identifying bone metastases in persons with prostate cancer: A systematic review.
    Daniels H, Gilbert R, Bonin L.
    J Med Imaging Radiat Sci; 2023 Sep 18; 54(3):545-555. PubMed ID: 37211439
    [Abstract] [Full Text] [Related]

  • 8. Impact of uptake time on image quality of [68 Ga]Ga-PSMA-11 PET/CT.
    van der Sar ECA, Viol SLM, Braat AJAT, van Rooij R, Lam MGEH, de Jong HWAM, de Keizer B.
    Med Phys; 2023 Dec 18; 50(12):7619-7628. PubMed ID: 37093883
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Ga-68 PSMA positron emission tomography/computerized tomography with Tc-99m MDP bone scan in prostate cancer patients.
    Uslu-Beşli L, Sağer S, Akgün E, Asa S, Şahin OE, Demirdağ Ç, Güner E, Khosroshahi BR, Karayel E, Pehlivanoğlu H, Aygün A, Uslu İ, Talat Z, Sönmezoğlu K.
    Turk J Med Sci; 2019 Feb 11; 49(1):301-310. PubMed ID: 30761859
    [Abstract] [Full Text] [Related]

  • 10. Intraindividual Comparison of 99mTc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand 99mTc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer.
    Rathke H, Afshar-Oromieh A, Giesel FL, Kremer C, Flechsig P, Haufe S, Mier W, Holland-Letz T, De Bucourt M, Armor T, Babich JW, Haberkorn U, Kratochwil C.
    J Nucl Med; 2018 Sep 11; 59(9):1373-1379. PubMed ID: 29371410
    [Abstract] [Full Text] [Related]

  • 11. A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide imaging of prostate cancer skeletal metastases.
    Lawal IO, Mokoala KMG, Mahapane J, Kleyhans J, Meckel M, Vorster M, Ebenhan T, Rösch F, Sathekge MM.
    Eur J Nucl Med Mol Imaging; 2021 Jan 11; 48(1):134-142. PubMed ID: 32424485
    [Abstract] [Full Text] [Related]

  • 12. Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?
    Simsek DH, Sanli Y, Civan C, Engin MN, Isik EG, Ozkan ZG, Kuyumcu S.
    Ann Nucl Med; 2020 Jul 11; 34(7):476-485. PubMed ID: 32394269
    [Abstract] [Full Text] [Related]

  • 13. Total-Body 68Ga-PSMA-11 PET/CT for Bone Metastasis Detection in Prostate Cancer Patients: Potential Impact on Bone Scan Guidelines.
    Pomykala KL, Czernin J, Grogan TR, Armstrong WR, Williams J, Calais J.
    J Nucl Med; 2020 Mar 11; 61(3):405-411. PubMed ID: 31541035
    [Abstract] [Full Text] [Related]

  • 14. How accurate is 68Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (68Ga-PSMA PET/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node- based analyses.
    Erdem S, Simsek DH, Degirmenci E, Aydin R, Bagbudar S, Ozluk Y, Sanli Y, Sanli O, Ozcan F.
    Urol Oncol; 2022 Jan 11; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [Abstract] [Full Text] [Related]

  • 15. Intra-individual comparison of prostate-specific membrane antigen positron emission tomography/computed tomography versus bone scan in detecting skeletal metastasis at prostate cancer diagnosis.
    Shanmugasundaram R, Saad J, Heyworth A, Wong V, Pelecanos A, Arianayagam M, Canagasingham B, Ferguson R, Goolam AS, Khadra M, Kam J, Ko R, McCombie S, Varol C, Winter M, Mansberg R, Nguyen D, Bui C, Loh H, Le K, Roberts MJ.
    BJU Int; 2024 Feb 11; 133 Suppl 3():25-32. PubMed ID: 37943964
    [Abstract] [Full Text] [Related]

  • 16. 68Ga-PSMA-PET/CT in comparison with 18F-fluoride-PET/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer: a prospective diagnostic accuracy study.
    Dyrberg E, Hendel HW, Huynh THV, Klausen TW, Løgager VB, Madsen C, Pedersen EM, Pedersen M, Thomsen HS.
    Eur Radiol; 2019 Mar 11; 29(3):1221-1230. PubMed ID: 30132104
    [Abstract] [Full Text] [Related]

  • 17. The meta-analysis of the effect of 68Ga-PSMA-PET/CT diagnosis of prostatic cancer compared with bone scan.
    Zhao R, Li Y, Nie L, Qin K, Zhang H, Shi H.
    Medicine (Baltimore); 2021 Apr 16; 100(15):e25417. PubMed ID: 33847640
    [Abstract] [Full Text] [Related]

  • 18. Prospective Comparison of PET Imaging with PSMA-Targeted 18F-DCFPyL Versus Na18F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer.
    Rowe SP, Li X, Trock BJ, Werner RA, Frey S, DiGianvittorio M, Bleiler JK, Reyes DK, Abdallah R, Pienta KJ, Gorin MA, Pomper MG.
    J Nucl Med; 2020 Feb 16; 61(2):183-188. PubMed ID: 31451492
    [Abstract] [Full Text] [Related]

  • 19. Bone metastases in prostate cancer - Gallium-68-labeled prostate-specific membrane antigen or Fluorine 18 sodium fluoride PET/computed tomography - the better tracer?
    Agrawal A, Natarajan A, Mithun S, Bakshi G, Joshi A, Murthy V, Menon S, Purandare N, Shah S, Puranik A, Choudhury S, Prakash G, Pal M, Maitre P, Prabhash K, Noronha V, Rangarajan V.
    Nucl Med Commun; 2022 Dec 01; 43(12):1225-1232. PubMed ID: 36345767
    [Abstract] [Full Text] [Related]

  • 20. Comparison of Bone Uptake in Bone Scan and Ga-68 PSMA PET/CT Images in Patients with Prostate Cancer.
    Acar E, Bekiş R, Polack B.
    Curr Med Imaging Rev; 2019 Dec 01; 15(6):589-594. PubMed ID: 32008568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.